Status:
UNKNOWN
Physical,Histological,and Genetic Analyses of Lipid-rich Atherosclerotic Plaques
Lead Sponsor:
Sheba Medical Center
Collaborating Sponsors:
University Hospital Goettingen
Carmel Medical Center
Conditions:
Atherosclerosis
Aortic Aneurysm
Eligibility:
All Genders
18+ years
Brief Summary
Lipid-rich atherosclerotic plaques, or "vulnerable plaques" are prone to rupture, causing local intravascular thrombosis, with subsequent grave clinical consequences. Atherosclerotic plaques normally ...
Eligibility Criteria
Inclusion
- Evidence of symptomatic carotid stenosis exceeding 60%(TIAs or stroke within the last 6 months), and asymptomatic carotid artery stenosis (presenting with progressive carotid stenosis, exceeding 70%)
- Abdominal aortic aneurysm, and aortic occlusive disease
- Peripheral occlusive or aneurysmal disease
Exclusion
- Non-compliant patients, incapable of granting approval by informed consent
Key Trial Info
Start Date :
March 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00449306
Start Date
March 1 2001
End Date
July 1 2021
Last Update
July 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center, Tel Hashomer
Ramat Gan, Israel, 52621